NEW YORK, Sept. 28 (GenomeWeb News) - Nanogen expects to raise nearly $20 million through a stock offering to institutional investors scheduled to close today, the company said.
The San Diego-based company will sell 6.8 million shares of its common stock to investors at a price of nearly $3 per share, with 1 million warrants exercisable at $4 per share for five years.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.